Northwell Receives $100K State Grant

To support behavioral health center for children and teens

Northwell Health today announced that it has received a $100,000 grant from New York State to support its Behavioral Health Center in Rockville Centre, which provides mental health care to children and teens in a collaborative arrangement with nine Nassau County school districts.

Northwell Health notes the grant was facilitated by State Senator Todd Kaminsky, who was instrumental in the health center’s launch in 2020 to fill a gap in mental health care that has left many families struggling to find timely help for children struggling with mental health.

While it typically takes parents eight weeks or more to arrange an appointment with a mental health provider, the Center’s child psychiatrist and licensed mental health counselors deliver same-day attention to students who may be either referred by participating schools or self-referred — evaluating them, developing a treatment plan and continuing to provide care until transfer to a community provider is arranged. The new grant will allow the Center to hire a dedicated Care Management Coordinator to connect students to longer-term care and assist families in navigating community mental health resources to find the best fit for their child. The new position will also free counselors at the Center to see more patients.

“The pandemic has exacerbated what was already a crisis of emotional distress among children and adolescents, but a severe shortage of adolescent mental health specialists makes it difficult for parents to find timely help,” said psychiatrist Vera Feuer, MD, the Center’s medical director. “The need is overwhelming both parents and schools. The Behavioral Health Center has helped to fill that gap and now will be able to meet the needs of even more students thanks to this grant.”

The Center has been working at full capacity since it opened in 2020, and Northwell opened a second Behavioral Health Center in Minneola last year. The two Centers have provided urgent behavioral health care to more than 2,000 students so far.

The Centers are made possible by a unique collaboration between Northwell’s Cohen Children’s Medical Center in New Hyde Park, Long Island school districts and Senator Todd Kaminsky, who saw the need for a new model of community-embedded care. Senator Kaminsky worked with Northwell and the school districts to develop an innovative way to fund the project, with fee-for-service covering part of the costs, districts providing a portion and Northwell absorbing the rest.

Nine school districts participate in the Behavioral Health Center in Rockeville Centre: East Rockaway, Freeport, Hewlett-Woodmere, Lawrence, Malverne, Oceanside, Rockville Centre, Valley Stream Central High School District and West Hempstead.

“There is a clear and pressing need to expand resources for children and teens struggling with mental health,” State Senator Kaminsky said. “The Behavioral Health Center in Rockville Centre has already played an instrumental role in providing care to hundreds of students and this grant will boost their capacity to work with even more. I am proud to have played a role in supporting that work and I applaud the staff’s dedication to providing this critical service to our communities.”

The Center is part of Northwell’s ongoing effort to meet the behavioral health needs of children and teens, which includes both emergency behavioral health services and a Pediatric Behavioral Health Urgent Care Center in Cohen Children’s Medical Center. In addition, in a program launched in 2017 by Northwell’s dedicated psychiatric facility, South Oaks Hospital, a child psychiatrist regularly visits schools in districts across Long Island to provide drop-in mental health services for students.

“Children and teens are suffering, and parents and schools need help in order to provide support,” said Charles Schleien, MD, senior vice president and chair of pediatric services at Northwell Health and the Philip Lanzkowsky Professor of Pediatrics. “This is a priority for Northwell, and we’re grateful to New York State for making it possible for us to expand the help we can provide.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”